Literature DB >> 8380064

Antisense suppression of transferrin receptor gene expression in a human hepatoma cell (HuH-7) line.

K Sasaki1, O Zak, P Aisen.   

Abstract

A recombinant plasmid carrying human transferrin receptor cDNA in reverse orientation downstream from the human cytomegalovirus immediate early promoter/enhancer element was introduced into the HuH-7 human hepatoma cell line by lipofection. Cell surface transferrin binding and iron uptake from transferrin each decreased by about 50% in stable transfectants bearing integrated antisense DNA expression vector. Northern blot analysis indicated that the abundance of target transferrin receptor message was not altered by antisense RNA. These results suggest that the antisense transcript interferes with expression of the endogenous transferrin receptor gene at the level of translation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380064     DOI: 10.1002/ajh.2830420115

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation.

Authors:  Jolyn Turner; Constantinos Koumenis; Timothy E Kute; Roy P Planalp; Martin W Brechbiel; Dillon Beardsley; Brooke Cody; Kevin D Brown; Frank M Torti; Suzy V Torti
Journal:  Blood       Date:  2005-07-12       Impact factor: 22.113

2.  Characterization of the interaction between diferric transferrin and transferrin receptor 2 by functional assays and atomic force microscopy.

Authors:  Katsuya Ikuta; Alexandre Yersin; Atsushi Ikai; Philip Aisen; Yutaka Kohgo
Journal:  J Mol Biol       Date:  2010-01-22       Impact factor: 5.469

3.  Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39.

Authors:  J Kawanishi; J Kato; K Sasaki; S Fujii; N Watanabe; Y Niitsu
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.